A critical translational challenge is the enhancement of RBC preservation conditions
Negrao MV , Molkentine D, Paula AG, Hover L, Nilsson M, Vokes N, Engstrom L, Calinisan A, Waters L, Briere DM, Hallin J, Blumenschein GR, Skoulidis F, Kopetz SE , Hong DS, Gibbons DL, Olson P, Christensen J, Heymach JV
For patients eager to see results, this means injectable therapy may show appetite suppression 3-5 days faster than tablets
Some patients experience hypoglycaemia (low blood sugar), particularly if taking Saxenda alongside other diabetes medications such as sulphonylureas or insulin, though this is less common in patients without diabetes
Finally, we validated that the peptide inhibitor exhibited robust selectivity for senescent cells and efficiently disrupted FOXO4-p53 foci formation despite its short length and L-type amino acid composition